These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35787936)

  • 1.
    van Leeuwen PJ; Emmett L
    Eur Urol; 2022 Nov; 82(5):510-511. PubMed ID: 35787936
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Kathia De Man, Nick Van Laeken, Vanessa Schelfhout, et al.
    Montorsi F; Gandaglia G; Robesti D; Dehò F; Briganti A
    Eur Urol; 2022 Nov; 82(5):e143. PubMed ID: 35989206
    [No Abstract]   [Full Text] [Related]  

  • 3.
    De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
    Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Highlight:
    Fütterer JJ; Nagarajah J
    Korean J Radiol; 2022 Mar; 23(3):293-294. PubMed ID: 35213092
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidental finding of COVID-19 infection after [
    Stasiak CES; Cardoso FR; de Almeida SA; Rosado-de-Castro PH
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):653-654. PubMed ID: 32710224
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging.
    Masters SC; Hofling AA; Gorovets A; Marzella L
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):27-28. PubMed ID: 33857629
    [No Abstract]   [Full Text] [Related]  

  • 7. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the most commonly-used radiopharmaceuticals for PSMA prostate PET/CT imaging.
    Pasini E; Panagiotidis E; Zoglopitou LA; Kalathas T; Makridou A; Chatzipavlidou V
    Hell J Nucl Med; 2022; 25(1):83-87. PubMed ID: 35388805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Evangelista L; Maurer T; van der Poel H; Alongi F; Kunikowska J; Laudicella R; Fanti S; Hofman MS
    Eur Urol Oncol; 2022 Jun; 5(3):273-282. PubMed ID: 35367165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Pros and Cons in Using [
    Maisto C; Aurilio M; Morisco A; de Marino R; Buonanno Recchimuzzo MJ; Carideo L; D'Ambrosio L; Di Gennaro F; Esposito A; Gaballo P; Pirozzi Palmese V; Porfidia V; Raddi M; Rossi A; Squame E; Lastoria S
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cardiac metastasis detected on serial imaging with [
    Das JP; Yeh R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3952-3953. PubMed ID: 35543730
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Bonacina M; Ghirardelli P; Setti L; Vavassori V; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):781-782. PubMed ID: 34453202
    [No Abstract]   [Full Text] [Related]  

  • 13. The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml.
    Lengana T; Lawal I; Janse Van Rensburg C; Mokoala K; Moshokoa E; Mazibuko S; Van de Wiele C; Maes A; Vorster M; Sathekge MM
    Nuklearmedizin; 2022 Apr; 61(2):120-129. PubMed ID: 35421900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer GTV delineation with biparametric MRI and
    Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiopsy
    Albisinni S; Sarkis J; Diamand R; De Nunzio C
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):47-49. PubMed ID: 36085498
    [No Abstract]   [Full Text] [Related]  

  • 16. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.
    Park SY; Zacharias C; Harrison C; Fan RE; Kunder C; Hatami N; Giesel F; Ghanouni P; Daniel B; Loening AM; Sonn GA; Iagaru A
    Radiology; 2018 Aug; 288(2):495-505. PubMed ID: 29786490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of
    Fendler WP; Ferdinandus J; Czernin J; Eiber M; Flavell RR; Behr SC; Wu IK; Lawhn-Heath C; Pampaloni MH; Reiter RE; Rettig MB; Gartmann J; Murthy V; Slavik R; Carroll PR; Herrmann K; Calais J; Hope TA
    J Nucl Med; 2020 Dec; 61(12):1793-1799. PubMed ID: 32358094
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Calais J; Ceci F; Eiber M; Hope TA; Hofman MS; Rischpler C; Bach-Gansmo T; Nanni C; Savir-Baruch B; Elashoff D; Grogan T; Dahlbom M; Slavik R; Gartmann J; Nguyen K; Lok V; Jadvar H; Kishan AU; Rettig MB; Reiter RE; Fendler WP; Czernin J
    Lancet Oncol; 2019 Sep; 20(9):1286-1294. PubMed ID: 31375469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-individual dynamic comparison of
    Piron S; Verhoeven J; Descamps B; Kersemans K; De Man K; Van Laeken N; Pieters L; Vral A; Vanhove C; De Vos F
    Sci Rep; 2020 Dec; 10(1):21068. PubMed ID: 33273603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Agony and Ecstasy of Prostate Cancer PSMA PET.
    Gomella LG
    Can J Urol; 2021 Apr; 28(2):10574-10575. PubMed ID: 33872551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.